Not applicableStudy completedNCT02465424What this trial is testingAssessing Quality of Life Tools in Medullary Thyroid Cancer PatientsWho this might be right forMedullary Thyroid Cancer Velindre NHS Trust 173
Testing effectiveness (Phase 2)Study completedNCT00121628What this trial is testingA Phase 2, Open-label Study of AMG 706 to Treat Subjects With Locally Advanced or Metastatic Thyroid CancerWho this might be right forThyroid Cancer Amgen 184
Testing effectiveness (Phase 2)Study completedNCT01882816What this trial is testingIntensity-Modulated Radiation Therapy (IMRT) in the Treatment of Non-Anaplastic Non-Medullary Thyroid CancerWho this might be right forThyroid Cancer Memorial Sloan Kettering Cancer Center 27
Large-scale testing (Phase 3)UnknownNCT01373736What this trial is testing123I-MIBG Scintigraphy in Patients Being Evaluated for Neuroendocrine TumorsWho this might be right forPheochromocytomaNeuroblastomaParaganglioma+2 more Vancouver Coastal Health
Not applicableUnknownNCT03643055What this trial is testing18F-Fluorocholine PET/CT in Medullary Thyroid CancerWho this might be right forMedullary Thyroid Cancer University Medical Centre Ljubljana 80
Not applicableStudy completedNCT04522570What this trial is testingThermal Ablation of Cervical Metastases From Thyroid CarcinomaWho this might be right forThyroid NeoplasiaWell-Differentiated Thyroid CancerMedullary Thyroid Cancer+1 more Instituto do Cancer do Estado de São Paulo 84
Not applicableStudy completedNCT05507775What this trial is testingDigoxin for the Reinduction of Radioiodine Uptake in Metastatic or Locally Advanced Non-medullary Thyroid CarcinomaWho this might be right forNon-Medullary Thyroid Carcinoma Radboud University Medical Center 8
Early research (Phase 1)Looking for participantsNCT07006727What this trial is testingPhase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid TumorsWho this might be right forSmall Cell Lung CarcinomaLarge Cell Neuroendocrine Carcinoma of the LungNeuroendocrine Prostate Cancer+8 more Novartis Pharmaceuticals 116
Testing effectiveness (Phase 2)Study completedNCT00096083What this trial is testingHepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver CancerWho this might be right forCancer Delcath Systems Inc. 56
Testing effectiveness (Phase 2)Study completedNCT01856920What this trial is testingQUILT-3.006 for Recurrent Medullary Thyroid CancerWho this might be right forMedullary Thyroid Cancer (MTC) NantCell, Inc. 35
Not applicableUnknownNCT03636945What this trial is testingEvaluation of 18F-FDOPA PET-CT in the Preoperative Initial Assessment of Medullary Thyroid CarcinomaWho this might be right forMedullary Thyroid Carcinoma Assistance Publique Hopitaux De Marseille 62
Post-approval studies (Phase 4)UnknownNCT01915485What this trial is testingRadiolabeled Molecules for Medullary Thyroid CancerWho this might be right forMedullary Thyroid Cancer Instituto Nacional de Cancer, Brazil 20
Early research (Phase 1)Active Not RecruitingNCT04514484What this trial is testingTesting the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIVWho this might be right forAdvanced Differentiated Thyroid Gland CarcinomaAdvanced Head and Neck CarcinomaAdvanced Hepatocellular Carcinoma+60 more National Cancer Institute (NCI) 8
Not applicableLooking for participantsNCT03892993What this trial is testingPatient Decision Aid in Supporting Decision-Making About When to Start or Stop New Drugs, Join Clinical Trials, or Continue Active Surveillance in Patients With Medullary Thyroid Cancer and Their CaregiversWho this might be right forThyroid Gland Medullary Carcinoma M.D. Anderson Cancer Center 120
Not applicableStudy completedNCT02268734What this trial is testingMolecular Profile of Metastatic Sporadic Medullary Thyroid Cancer Patients and Correlation With VandetanibWho this might be right forMetastatic Sporadic Medullary Thyroid Cancer Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 36
Not applicableEnded earlyNCT00416949What this trial is testingIodine I 131 in Treating Patients With Thyroid CancerWho this might be right forHead and Neck Cancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 9
Not applicableActive Not RecruitingNCT04970134What this trial is testingSpanish Study for Molecular Characterization of Thyroid CarcinomaWho this might be right forDifferentiated Thyroid CarcinomaMedullary Thyroid Carcinoma Grupo Español de Tratamiento de Tumores de Cabeza y Cuello 150
Not applicableEnrolling By InvitationNCT07713901What this trial is testingDatabase Linkage Study to Evaluate the Risk of Medullary Thyroid CarcinomaWho this might be right forMedullary Thyroid Carcinoma Novo Nordisk A/S 93,600,000
Not applicableEnrolling By InvitationNCT06852144What this trial is testingPET-TC in Thyroid EvaluationWho this might be right forMedullary Thyroid CarcinomaHyperparathyroidismParathyroid Carcinoma IRCCS Azienda Ospedaliero-Universitaria di Bologna 418
Testing effectiveness (Phase 2)Study completedNCT00004048What this trial is testingRadioimmunotherapy With or Without Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Thyroid CancerWho this might be right forHead and Neck Cancer Garden State Cancer Center at the Center for Molecular Medicine and Immunology 30